Since NB progression may also be affected by metabolic perturbations induced by the triple treatment, we measured the plasma levels of several metabolic peptides conceivably involved in NB progression, including leptin, MIP-2, FGF-21, GM-CSF, ghrelin, IP-10, MCP-1, and PYY (Figure 5). This evidence concerns the gene CCL2 and neuroblastoma.